SUN Pharmaceutical Industries Limited — Cefuroxime Exporter Profile
Indian Pharmaceutical Exporter · #1 for Cefuroxime · $16.8M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #1 Indian exporter of Cefuroxime with $16.8M in export value and 336 verified shipments. SUN Pharmaceutical Industries Limited holds a 13.0% market share in Cefuroxime exports across 9 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Cefuroxime Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Cefuroxime?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $6.5M | 184 | 62.7% |
| BELGIUM | $3.4M | 130 | 32.2% |
| TRINIDAD & TOBAGO | $141.2K | 4 | 1.4% |
| ZIMBABWE | $74.1K | 7 | 0.7% |
| TRINIDAD AND TOBAGO | $69.3K | 4 | 0.7% |
| SOUTH AFRICA | $67.1K | 6 | 0.6% |
| UNITED ARAB EMIRATES | $50.0K | 1 | 0.5% |
| PERU | $47.2K | 4 | 0.5% |
| TRINIDAD TOBAGO | $46.1K | 2 | 0.4% |
| MYANMAR | $29.2K | 1 | 0.3% |
SUN Pharmaceutical Industries Limited exports Cefuroxime to 11 countries. The largest destination is BRAZIL accounting for 62.7% of SUN Pharmaceutical Industries Limited's Cefuroxime shipments, followed by BELGIUM (32.2%) and TRINIDAD & TOBAGO (1.4%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cefuroxime from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S. RANBAXY FARMACEUTICA LTDA : | BRAZIL | $2.5M | 69 |
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $2.5M | 93 |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $815.9K | 34 |
| M/S. RANBAXY FARMACEUTICA LTDA. | BRAZIL | $534.2K | 12 |
| MS ACHE LABORATORIOS FARMACEUTICO SSARODOVIA | BRAZIL | $350.0K | 7 |
| M S RANBAXY FARMACEUTICA LTDA | BRAZIL | $342.6K | 8 |
| M/S. RANBAXY FARMACEUTICA LTDA, | BRAZIL | $332.5K | 7 |
| M/S. ACH LABORATRIOS FARMACUTICO | BRAZIL | $287.9K | 6 |
| RANBAXY FARMACEUTICA LTDA | BRAZIL | $261.0K | 12 |
| M/S. ACHE LABORATORIOS FARMACEUTICO | BRAZIL | $254.3K | 6 |
SUN Pharmaceutical Industries Limited supplies Cefuroxime to 45 buyers globally. The largest buyer is M/S. RANBAXY FARMACEUTICA LTDA : (BRAZIL), followed by YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM) and YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cefuroxime Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $82.9M worth of Cefuroxime through 6,961 shipments from 440 suppliers to 150 countries, serving 1,458 buyers globally. SUN Pharmaceutical Industries Limited contributes $16.8M to this total, accounting for 13.0% of India's Cefuroxime exports. SUN Pharmaceutical Industries Limited ships Cefuroxime to 11 countries through 45 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Cefuroxime Exports?
SUN Pharmaceutical Industries Limited's average Cefuroxime shipment value is $50.0K per consignment, based on 336 shipments totaling $16.8M. The largest destination is BRAZIL (62.7% of SUN Pharmaceutical Industries Limited's Cefuroxime exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Cefuroxime Exporters?
SUN Pharmaceutical Industries Limited ranks #1 among 440 Indian Cefuroxime exporters with a 13.0% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($18.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($16.8M), ALKEM LABORATORIES LIMITED ($11.6M). SUN Pharmaceutical Industries Limited processed 336 shipments to 9 destination countries.
What Cefuroxime Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CEFUROXIME AXE. TABLETS 500MG PACK: 10s | $200.0K | 4 |
| CEFUROXIME AXETIL SUS 250MGBRAZ 50ml P | $200.0K | 4 |
| CEFUROXIME AXE. TABLETS 500MG PACK:10s S | $150.0K | 3 |
| CEFUROX BASICS TAB 500MG PACK : 12S STRIP BATCH : DFE7467A, DFE8059B EACH TAB CONTS: CEFUROXIME AXETIL PH.EUR EQ TO CEFUPCS | $150.0K | 3 |
| CEFUROXIME AXETIL SUS PACK: 70ml Bottl B | $132.7K | 3 |
| CEFUROX BASICS TAB 500MG PACK : 12S STRIP BATCH : DFE7435A EACH TAB CONTS: CEFUROXIME AXETIL PH.EUR EQ TO CEFUROXIME 500PCS | $124.3K | 3 |
| CEFUROX BASICS TAB 500MG PACK : 14S STRIP BATCH : DFF0184B EACH TAB CONTS: CEFUROXIME AXETIL PH.EUR EQ TO CEFUROXIME 500PCS | $116.8K | 3 |
| CEFUROXIME AXETIL TAB 250MG 14'S BRAZ PA | $100.0K | 2 |
| CEFUROXIME AXETIL SUS PACK:70ML BOTTL BA | $100.0K | 2 |
| CEFUROXIME AXETIL TAB 500MG PACK:14s S | $100.0K | 2 |
SUN Pharmaceutical Industries Limited exports 279 distinct Cefuroxime formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CEFUROXIME AXE. TABLETS 500MG PACK: 10s with 4 shipments worth $200.0K.
Regulatory Requirements: Exporting Cefuroxime to Key Markets
What SUN Pharmaceutical Industries Limited must comply with to export Cefuroxime to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Cefuroxime Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | AUROBINDO PHARMA LTD | $18.5M | 706 | 24 | $26.2K |
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $16.8M | 336 | 9 | $50.0K |
| 3 | ALKEM LABORATORIES LIMITED | $11.6M | 231 | 14 | $50.0K |
| 4 | AUROBINDO PHARMA LIMITED | $8.0M | 266 | 16 | $30.1K |
SUN Pharmaceutical Industries Limited ranks #1 among 440 Indian Cefuroxime exporters. Average shipment value of $50.0K compared to the market average of $188.4K. The closest competitors by value are AUROBINDO PHARMA LTD and ALKEM LABORATORIES LIMITED.
Which Indian Ports Ship Cefuroxime Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 707 | 10.2% |
| SAHAR AIR | 670 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 661 | 9.5% |
| HYDERABAD ICD | 316 | 4.5% |
| DELHI AIR | 312 | 4.5% |
| DELHI AIR CARGO ACC (INDEL4) | 300 | 4.3% |
| JNPT/ NHAVA SHEVA SEA | 281 | 4.0% |
| HYDERABAD ICD (INSNF6) | 278 | 4.0% |
What Other Advanced Antibiotics Products Does SUN Pharmaceutical Industries Limited Export?
SUN Pharmaceutical Industries Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Cefuroxime Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Cefuroxime, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cefuroxime — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cefuroxime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 344 individual customs records matching SUN Pharmaceutical Industries Limited exporting Cefuroxime, covering 279 formulations to 11 countries via 45 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 1,458+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cefuroxime Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Cefuroxime exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Cefuroxime Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cefuroxime. For current shipment-level data, contact TransData Nexus.